Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

Human Follistatin ELISA Kit: Essential for Myostatin Pathway and Muscle Biology

The Human Follistatin ELISA Development Kit represents a cutting-edge analytical tool designed for the precise quantification of human follistatin in various biological matrices. This sophisticated sandwich enzyme-linked immunosorbent assay (ELISA) system provides researchers with a reliable platform to investigate the complex roles of this crucial glycoprotein in metabolic regulation, muscular development, and reproductive physiology. With its exceptional sensitivity and robust performance characteristics, the kit enables accurate detection of follistatin across physiologically relevant concentrations, making it an invaluable asset for both basic research and therapeutic development applications.

Follistatin

Follistatin is a multifunctional glycoprotein that plays pivotal roles in numerous biological processes through its ability to bind and neutralize members of the transforming growth factor-β (TGF-β) superfamily, particularly activins and myostatin. Originally identified as a follicle-stimulating hormone (FSH) suppressor in the pituitary gland, follistatin has since been recognized as a key regulator in muscle growth, metabolic homeostasis, and reproductive function. The protein exists in multiple isoforms derived from alternative splicing and post-translational modifications, with follistatin-315 and follistatin-288 being the predominant circulating forms.

Structure of Follistatin.Figure 1.Structure of Follistatin.

Introduction

The significance of follistatin quantification extends across multiple research domains. In muscular biology, follistatin serves as a potent negative regulator of myostatin, thereby promoting muscle hypertrophy and regeneration. In metabolic research, follistatin influences glucose metabolism and insulin sensitivity through its interactions with activins. Furthermore, follistatin plays critical roles in ovarian folliculogenesis, embryonic development, and wound healing processes. The development of reliable follistatin detection methods is therefore essential for advancing our understanding of these complex physiological systems and their associated pathologies. This ELISA development kit employs a sophisticated sandwich immunoassay format that ensures high specificity and sensitivity. The system utilizes a monoclonal antibody pre-coated onto microplates for optimal antigen capture, combined with a highly specific detection antibody that recognizes distinct epitopes on the follistatin molecule. The assay incorporates advanced signal amplification technology, providing researchers with the flexibility to optimize detection parameters according to their specific experimental requirements while maintaining excellent reproducibility and linearity across the measurable range.

Technology Platform

Sample Compatibility

  • TBD

Sensitivity Range

  • High Sensitivity
  • Broad Dynamic Range
  • Low Limit of Detection
  • High Precision

Main Uses

  • Diagnosis
  • Risk screening
  • Outbreak screening

Product Specifications and Performance

Product Specifications

  • Detection Method: Sandwich ELISA
  • Sample Type: Serum, plasma, cell culture supernatant, tissue homogenates
  • Assay Time: 4-5 hours (including incubation and development steps)
  • Detection Range: 0.1-50 ng/mL
  • Sensitivity:<0.05 ng/mL
  • Precision: Intra-assay CV<7%; Inter-assay CV <10%
  • Specificity: Recognizes multiple follistatin isoforms with minimal cross-reactivity to related TGF-β family proteins
  • Sample Volume: 50-100 μL per test

Intended Use & Research Applications

  • This development kit is specifically designed to support comprehensive research investigations across multiple disciplines:
  • Metabolic disorder survey: to evaluate the role of follistatin in diabetes, obesity and related metabolic syndrome.
  • Progress in treatment: Monitoring the expression of follistatin in preclinical studies of myostatin pathway inhibitors and metabolic modulators.
  • Cancer research: Study on the involvement of follicle stimulating hormone in regulating tumor progression and metastasis.

Stability

  • Unopened kits maintain ≥ 90% of initial sensitivity for 12 months at 2–8°C (verified via monthly testing of batch reserves).
  • Diluted reagents (detection antibody, sample dilution buffer) retain ≥ 85% activity after 3 freeze-thaw cycles (from -20°C to 2–8°C), minimizing reagent waste and supporting flexible experimental scheduling.

Key Features of the Product

  • High Specificity: The monoclonal capture antibody and polyclonal detection antibody target non-overlapping epitopes of human FST, ensuring no cross-reactivity with MSTN or other related proteins—critical for accurate myostatin pathway studies.
  • User-Friendly Operation: Pre-coated microplates and ready-to-use reagents eliminate complex preparation steps (e.g., antibody coating, reagent dilution). The detailed manual includes standard curve plotting guidelines and troubleshooting tips, suitable for both novice and experienced researchers.

Human Follistatin ELISA Kit

ParameterDetails
Product nameHuman Follistatin ELISA Development Kit
SampleTBD
Intended UseHuman Follistatin ELISA Development Kit contains the key components required for the quantitative measurement of natural and/or recombinant Follistatin in a sandwich ELISA format. Using the ELISA protocol described below, this kit provides sufficient reagents to assay Follistatin in approximately 1500 ELISA plate wells.
General DescriptionFollistatin (FST) is a glycosylated single-chain protein. It specifically inhibits the secretion of FSH from the pituitary. Follistatin/activin-binding protein binds to heparan sulfate side chains of proteoglycans on the granulosa cell surface to regulate the various actions of activin. Follistatin regulates a variety of biological functions, including cell proliferation, differentiation, and apoptosis. Follistatin plays a critical role in the production of multiple-organ metastasis, predominantly by inhibiting the angiogenesis.3
StorageStore the kit reagents at 2-8°C. For more detailed information, please download the following document on our website.
Standard Curve

Application Advantage: Optimized for Muscle Samples

Follistatin.

Unlike general-purpose ELISA kits, this kit is tailored to muscle biology research:

Validated for muscle cell culture supernatants (e.g., C2C12 myoblasts, primary human myotubes), a key sample type in myostatin pathway studies—many competing kits only support serum/plasma.

The sample dilution buffer contains protease inhibitors to prevent FST degradation in muscle cell supernatants (FST is prone to proteolysis in cell culture media), ensuring reliable results.

Advantages

Exceptional Sensitivity for Critical Low-Level Detection

This kit is engineered for high sensitivity, capable of accurately quantifying the low levels of progesterone present in the follicular phase of the menstrual cycle and in men. This is essential for obtaining clinically meaningful data across all physiological states.

High Specificity

The monoclonal capture antibody and polyclonal detection antibody target non-overlapping epitopes of human FST, ensuring no cross-reactivity with MSTN or other related proteins—critical for accurate myostatin pathway studies.

User-Friendly Operation

Pre-coated microplates and ready-to-use reagents eliminate complex preparation steps (e.g., antibody coating, reagent dilution). The detailed manual includes standard curve plotting guidelines and troubleshooting tips, suitable for both novice and experienced researchers.

Conclusion

The Human Follistatin ELISA Development Kit provides researchers with a sophisticated and versatile tool for investigating this important regulatory protein across multiple physiological systems. The combination of exceptional sensitivity, broad isoform recognition, and development flexibility makes this kit particularly valuable for advancing our understanding of follistatin's roles in muscle biology, metabolic regulation, and reproductive function. With its robust performance characteristics and comprehensive support resources, this development kit serves as an ideal platform for both basic research and therapeutic development applications in these rapidly evolving fields of biomedical science.

Frequently Asked Questions (FAQs)

Antibody FAQs

Still have questions?

Contact Us

A1: Follistatin functions as a potent endogenous inhibitor of myostatin, a key negative regulator of muscle growth. The follistatin-myostatin axis represents a crucial pathway controlling muscle mass and regeneration. Accurate quantification of follistatin is therefore essential for understanding muscle physiology and developing therapeutic strategies for muscle-wasting disorders.

A2: The kit employs carefully selected antibody pairs that recognize epitopes conserved across major follistatin isoforms. While the detection efficiency may vary slightly between isoforms, the assay provides comprehensive detection capability for both follistatin-315 and follistatin-288, along with other minor variants. Researchers can refer to the detailed cross-reactivity data provided in the kit documentation.

A3: For tissue samples, we recommend homogenization in appropriate buffer systems followed by centrifugation to remove insoluble material. The supernatant should be aliquoted and stored at -80°C until analysis. Optimal homogenization protocols may vary by tissue type, and researchers should consider implementing protease inhibitors to maintain protein integrity during processing.

A4: Yes, the basic assay format is compatible with automation and can be scaled for higher throughput applications. The development kit format provides researchers with the flexibility to optimize parameters for automated liquid handling systems while maintaining assay performance characteristics.

Inquiry Basket
loading Loading ......

Inquiry

Inquiry